Neuren Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:NEU Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Aug 24	BuyAU$100,766	Joe Basile	Individual	6,406	AU$15.73
17 Jul 24	BuyAU$132,031,307	Milford Asset Management, LTD	Company	8,499,600	AU$15.53
17 Jul 24	SellAU$131,556,262	Milford Asset Management, LTD	Company	9,003,256	AU$14.61
11 Jun 24	BuyAU$97,450	Joe Basile	Individual	5,000	AU$19.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NEU?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	404,072	0.316%
Individual Insiders	4,235,331	3.31%
Private Companies	12,359,012	9.67%
Institutions	20,459,900	16%
General Public	90,324,496	70.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 29.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.98%	The Vanguard Group, Inc.	6,367,361	AU$77.3m	0.45%	no data
4.74%	Milford Asset Management, LTD	6,058,321	AU$73.5m	-7.68%	0.99%
3.23%	Cameron Richard Pty Limited	4,123,084	AU$50.1m	0%	no data
2.06%	Stuart Andrew Pty. Ltd.	2,633,787	AU$32.0m	0%	no data
1.95%	Norges Bank Investment Management	2,486,288	AU$30.2m	0%	no data
1.89%	Trevor Scott	2,414,784	AU$29.3m	0%	no data
1.81%	BlackRock, Inc.	2,314,916	AU$28.1m	4.25%	no data
1.46%	Smithley Super Pty. Limited	1,870,000	AU$22.7m	0%	no data
1.38%	Linwierik Super Pty. Limited	1,761,385	AU$21.4m	0%	no data
0.72%	BetaShares Capital Limited	917,270	AU$11.1m	7.46%	0.04%
0.59%	First Colby Co Pty Ltd	750,000	AU$9.1m	0%	no data
0.59%	Mjhft Pty Ltd	750,000	AU$9.1m	0%	no data
0.53%	Robin Congreve	671,637	AU$8.2m	0%	no data
0.41%	State Street Global Advisors, Inc.	522,065	AU$6.3m	-0.34%	no data
0.38%	Goldman Sachs Asset Management, L.P.	481,489	AU$5.8m	369%	no data
0.37%	Emancipayte Pty ltd	470,756	AU$5.7m	0%	no data
0.33%	Netwealth Investments Ltd.	421,309	AU$5.1m	0%	0.04%
0.32%	He Zhao	405,000	AU$4.9m	0%	no data
0.32%	Pfizer Inc.	404,072	AU$4.9m	0%	no data
0.31%	Jonathan Pilcher	398,207	AU$4.8m	0%	no data
0.31%	Jupiter Fund Management Plc	396,906	AU$4.8m	0%	0.01%
0.21%	Patrick Donald Davies	264,634	AU$3.2m	0%	no data
0.16%	Charles Schwab Investment Management, Inc.	210,311	AU$2.6m	4.59%	no data
0.12%	Nordea Investment Management, AB	149,709	AU$1.8m	0%	no data
0.12%	Dimensional Fund Advisors LP	149,393	AU$1.8m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 23:00
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neuren Pharmaceuticals Limited is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Russell Wright	Barclay Pearce Capital Pty Limited
Thomas Wakim	Bell Potter
Tara Speranza	Bell Potter